ERBB2 and breast carcinoma: Significant indicators from the multivariate COX regression analysis were included in the prediction model development options, programmed using R software, and finally made into a prediction model based on clinical stage, HER2, RCB grading, and Tils grading system to assess the prognostic outcome of non-PCR patients after neoadjuvant therapy for breast cancer.